NDC 70710-1746 – dasatinib
Dasatinib 140 mg/1 · Tablet · Oral
Product NDC70710-1746
Product details
- Brand name
- dasatinib
- Generic name
- dasatinib
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA218719
- Marketed since
- March 3, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Dasatinib 140 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70710-1746-3 | 30 TABLET in 1 BOTTLE (70710-1746-3) | Mar 3, 2025 |
Other Dasatinib products
- 62332-687 Dasatinib 80 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-686 Dasatinib 70 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-685 Dasatinib 50 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-688 Dasatinib 100 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-684 Dasatinib 20 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-689 Dasatinib 140 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 46708-687 Dasatinib 80 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-688 Dasatinib 100 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-686 Dasatinib 70 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-689 Dasatinib 140 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-685 Dasatinib 50 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-684 Dasatinib 20 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited